Most of the drug overdoses are caused by opioids or fentanyl. In a move that health experts say may reduce the number of ...
The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid ...
By Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application ...
The US Food and Drug Administration (FDA) has approved the biosimilar ustekinumab-aekn (Selarsdi) for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in adults and ...
Instead, Galiatsatos said, the FDA approved the drug based on other signs of effectiveness, including whether patients were able to walk farther in six minutes than they could before they started ...
MORE: FDA approves the active ingredient in Mounjaro to help people with obesity lose weight, named Zepbound Wegovy, like Zepbound, is FDA-approved for weight loss. Its main ingredient is ...
Enhertu has been approved by the FDA for certain patients with unresectable or metastatic HER2-positive solid tumors. The Food and Drug Administration has granted Enhertu (fam-trastuzumab ...
Officials say more research is needed and these findings are just preliminary. Also, FDA approval does not guarantee insurance coverage. It’s still unclear if most insurance companies will cover ...
Due to adcomm panel meet, the FDA pushed the approval date for Abecma from 16 December 2023. Abecma helped extend the time before disease progression by 13.3 months vs. 4 months in standard care ...
The FDA has approved Alvotech’s (NASDAQ:ALVO) biosimilar of Johnson & Johnson’s (NYSE:JNJ) top-selling drug Stelara. The biosimilar, called Selarsdi, will be marketed in the US by Alvotech ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...